We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zora Biosciences Commercializes VTT's Biotechnology Expertise

News   Jun 27, 2007

 
Zora Biosciences Commercializes VTT's Biotechnology Expertise
 
 
 

RELATED ARTICLES

Insights on Marijuana and Opioid Use in People With Cancer

News

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

READ MORE

On-chip Drug Screening for Identifying Antibiotic Interactions in Eight Hours

News

A research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.

READ MORE

Blood Test for Detecting Pre-symptomatic Alzheimer's Disease is Refined

News

A research team have developed a method to detect the amyloid-beta (Aβ) peptide in human blood. They hope that their research will have implications in diagnosing and understanding the progression of Alzheimer's disease (AD).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE